This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
HIV-1 Infections
and you are
over 3
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The primary objective of this trial is to continue the provision of darunavir/ low-dose ritonavir (DRV/rtv) to adult and pediatric patients who previously received DRV/rtv in the clinical trials TMC114-C211, TMC114-C214, TMC114-TiDP31-C229 or in the pediatric trial TMC114-TiDP29-C232 who continue to benefit from the use of DRV/rtv, in countries where DRV is not commercially available for the subject, is not reimbursed, or cannot be accessed through another source (e.g., access program, governmental program).

Provided treatments

  • Drug: Darunavir
  • Drug: Ritonavir
  • Drug: Darunavir
  • Drug: Ritonavir
  • Drug: Darunavir
  • Drug: Darunavir
  • Drug: Ritonavir
  • Drug: Ritonavir

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03027297. The sponsor of the trial is Janssen Sciences Ireland UC and it is looking for 133 volunteers for the current phase.
Official trial title:
Continued Access to Darunavir/Ritonavir (DRV/Rtv) in HIV-1 Infected Adults, Adolescents and Children Aged 3 Years and Above